HCM
LEXXW

Heights Capital Management’s Lexaria Bioscience Warrant LEXXW Stock Holding History

Heights Capital Management’s Portfolio LEXXW Stock Details LEXXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-41,251
Closed -$3.3K – 205
2025
Q3 		$3.3K Hold
41,251
– – ﹤0.01% 174
2025
Q2 		$4.13K Hold
41,251
– – ﹤0.01% 150
2025
Q1 		$13.4K Hold
41,251
– – 0.01% 89
2024
Q4 		$35.1K Hold
41,251
– – 0.02% 76
2024
Q3 		$37.9K Buy
+41,251
New +$47.5K 0.03% 58

Other funds holding LEXXW

TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Heights Capital Management's LEXXW Position: Q4 2025 in Review

Heights Capital Management sold out of Lexaria Bioscience Warrant (LEXXW) in Q4 2025, closing a stake of 41,251 shares — an estimated $3.3K sold.

Heights Capital Management first reported a position in LEXXW in Q3 2024 and held it in 5 quarters. The position peaked at $37.9K in Q3 2024. 3 funds tracked by Wall St. Rank hold LEXXW as of Q4 2025.

  • Heights Capital Management reported no remaining Lexaria Bioscience Warrant position as of Q4 2025 after selling out during the quarter.
  • Heights Capital Management sold 41,251 Lexaria Bioscience Warrant shares in Q4 2025, an estimated $3.3K.
  • Heights Capital Management first reported a position in Lexaria Bioscience Warrant in Q3 2024 and held it in 5 quarters.
  • Heights Capital Management's Lexaria Bioscience Warrant position peaked at $37.9K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Lexaria Bioscience Warrant as of Q4 2025.

Based on Heights Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.